An Improved Stress Fracture Model to Study Drug Effects on Bone Damage Repair
An Improved Stress Fracture Model to Study Drug Effects on Bone Damage Repair
批准号:
8872907
负责人:
MATTHEW J SILVA
金额:
$20.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2017-03-31
关键词:
AcuteAddressAdverse effectsAdvisory CommitteesAffectAmericanAnimal ModelAnimalsBiologicalBiologyBone DensityBone RegenerationBone ResorptionBone callusBone remodelingCharacteristicsClinicalClinical effectivenessCoupledDefectDevelopmentDevicesExperimental ModelsFatigueFemoral FracturesForelimbFractureFracture HealingFunctional disorderFunding MechanismsFutureGoalsHealedHip FracturesImpaired wound healingIncidenceLateralLinkMeasuresMechanicsMedialMineralsModelingModificationOsteoclastsOsteoporosisPathogenesisPatientsPharmaceutical PreparationsProcessRattusReportingResearchResearch PersonnelRiskRoleSideSiteSocietiesStressStress FracturesTestingTimeUnited Statesacute stressbasebisphosphonatebonebone fatiguebone healthclinically relevanthealingimprovedin vivo Modelnovelpreventpublic health relevancerepairedstandard of caretime intervaltoolulna
中文摘要
英文摘要
DESCRIPTION (provided by applicant): There are 10 million people with osteoporosis in the U.S., and approximately one-half have been treated with bisphosphonates. Bisphosphonates suppress bone resorption, and are effective in increasing/maintaining bone mineral density and reducing fracture incidence. Recently, long-term bisphosphonate use has been linked to a newly recognized type of bone fracture called an atypical femoral fracture (AFF). Evidence suggests that AFFs are stress fractures that develop over time and do not heal. But the underlying causes and patient factors contributing to AFFs are not known. In general, stress fractures develop when bone microdamage propagates and coalesces faster than it can be repaired by osteoclast-initiated remodeling. Bisphosphonates may increase the risk of AFF by inhibiting bone resorption and the coupled remodeling that should repair bone microdamage. However, there is no direct evidence that suppression of damage-driven remodeling contributes to AFFs. One reason why the cause of AFFs is unknown is the lack of a suitable animal model to study the pathophysiology. In fact, the 2010 task force of the American Society of Bone and Mineral Research stated that "animal models that more accurately mimic atypical fractures need to be developed". The goal of this R21 project is to develop a novel stress fracture model with the key features of an atypical femur fracture. These features include: stress fracture developing on the tensile side, and presence of microdamage-driven bone remodeling prior to stress fracture. Current stress fracture models lack these clinically relevant features. With the new model we will begin to test the general hypothesis that bisphosphonates increase the risk of a non-healing stress fracture by interfering with targeted remodeling of bone microdamage. Development of a clinically relevant stress fracture model will provide a new tool to elucidate the pathogenesis of AFFs including the role of bisphosphonates. Development of a novel model that fits an unmet need in translational bone biology is appropriate to the R21 funding mechanism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Influence of Genetic Background on Bone Anabolic Response to Mechanical Loading
-
批准号:10373527
-
项目类别:
-
资助金额:$21.44万
-
财政年份:2022
-
负责人:MATTHEW J SILVA
-
依托单位:
Influence of Genetic Background on Bone Anabolic Response to Mechanical Loading
-
批准号:10553706
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2022
-
负责人:MATTHEW J SILVA
-
依托单位:
Musculoskeletal Structure and Strength Core
-
批准号:10602565
-
项目类别:
-
资助金额:$14.35万
-
财政年份:2019
-
负责人:MATTHEW J SILVA
-
依托单位:
Administrative Core
-
批准号:10388080
-
项目类别:
-
资助金额:$30.94万
-
财政年份:2019
-
负责人:MATTHEW J SILVA
-
依托单位:
Musculoskeletal Structure and Strength Core
-
批准号:10388081
-
项目类别:
-
资助金额:$14.67万
-
财政年份:2019
-
负责人:MATTHEW J SILVA
-
依托单位:
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)
-
批准号:10474676
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2019
-
负责人:MATTHEW J SILVA
-
依托单位:
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)
-
批准号:10388079
-
项目类别:
-
资助金额:$75.5万
-
财政年份:2019
-
负责人:MATTHEW J SILVA
-
依托单位:
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)
-
批准号:9920674
-
项目类别:
-
资助金额:$77.41万
-
财政年份:2019
-
负责人:MATTHEW J SILVA
-
依托单位:
Administrative Core
-
批准号:10602564
-
项目类别:
-
资助金额:$30.81万
-
财政年份:2019
-
负责人:MATTHEW J SILVA
-
依托单位:
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)
-
批准号:10602531
-
项目类别:
-
资助金额:$74.66万
-
财政年份:2019
-
负责人:MATTHEW J SILVA
-
依托单位:
3D X-RAY PHASE CONTRAST MICROSCOPE FOR SUBMICRON QUANTITATIVE BIOLOGICAL IMAGING
-
批准号:9075769
-
项目类别:
-
资助金额:$101.59万
-
财政年份:2016
-
负责人:MATTHEW J SILVA
-
依托单位:
The Effects of Systemic Hedgehog Pathway Modulation on Fracture Healing
-
批准号:9088364
-
项目类别:
-
资助金额:$16.78万
-
财政年份:2015
-
负责人:MATTHEW J SILVA
-
依托单位:
Musculoskeletal Structure and Strength
-
批准号:8375252
-
项目类别:
-
资助金额:$22.44万
-
财政年份:2012
-
负责人:MATTHEW J SILVA
-
依托单位:
Musculoskeletal Structure and Strength
-
批准号:8246482
-
项目类别:
-
资助金额:$20.71万
-
财政年份:2011
-
负责人:MATTHEW J SILVA
-
依托单位:
Core Center for Musculoskeletal Biology and Medicine
-
批准号:9269143
-
项目类别:
-
资助金额:$54.31万
-
财政年份:2009
-
负责人:MATTHEW J SILVA
-
依托单位:
IN VIVO MICROCT SYSTEM
-
批准号:7215440
-
项目类别:
-
资助金额:$31.71万
-
财政年份:2007
-
负责人:MATTHEW J SILVA
-
依托单位:
Stimulating Bone Formation using constrained Tibial Vibration
-
批准号:7496475
-
项目类别:
-
资助金额:$16.01万
-
财政年份:2007
-
负责人:MATTHEW J SILVA
-
依托单位:
Stimulating Bone Formation using constrained Tibial Vibration
-
批准号:7386467
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2007
-
负责人:MATTHEW J SILVA
-
依托单位:
OSTEOGENIC AND ANGIOGENIC RESPONSE TO SKELETAL LOADING
-
批准号:6890487
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2003
-
负责人:MATTHEW J SILVA
-
依托单位:
Osteogenic and Angiogenic Response to Skeletal Loading
-
批准号:7867981
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2003
-
负责人:MATTHEW J SILVA
-
依托单位:
海外基金